rxstat › Shortages › Ombitasvir Paritaprevir Ritonavir

Ombitasvir Paritaprevir Ritonavir shortage status

Discontinued

Source: Health Canada shortage reports · Updated Jul 9, 2026

Ombitasvir Paritaprevir Ritonavir products have been discontinued in Canada. See the reports below for which products and when.
Products affected
0 / 1
Reports on file
1

Reports by product

Discontinued
TECHNIVIE
12.5MG 75MG 50MG · TABLET · ABBVIE CORPORATION
DIN 02447711

What's happening

One or more Ombitasvir Paritaprevir Ritonavir products have been permanently discontinued by their manufacturers. If your product is affected, ask your pharmacist about equivalent products still on the market.

Ombitasvir Paritaprevir Ritonavir is classified under “DIRECT ACTING ANTIVIRALS” (ATC J05AX67).

Recent changes

Common questions

When will Ombitasvir Paritaprevir Ritonavir be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Ombitasvir Paritaprevir Ritonavir in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (direct acting antivirals)

Partial shortageAdefovir Dipivoxil1 of 2 reported products affectedPartial shortageAtazanavir3 of 8 reported products affectedPartial shortageDarunavir2 of 9 reported products affected · est. return Jul 24, 2026Partial shortageEfavirenz1 of 6 reported products affectedPartial shortageEfavirenz Tenofovir Disoproxil Emtricitabine3 of 7 reported products affected · est. return Dec 31, 2026Partial shortageEntecavir2 of 5 reported products affected · est. return Aug 7, 2026

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.